Success Stories: Postdoctoral Associate with 129 Citations in Virginia in the Field of Medicinal Chemistry Receives EB-1A Petition Approval a Year after Filing

Client’s Testimonial:

“Thank you very much for your professional and efficient assistance. I will definitely refer my friends who plan to file the green cards to your firm and will also recommend your firm on Mitbbs, since I got to know your law firm from Mitbbs. I already retained a lawyer before paying additional attorney fee to hire your law firm. Judging from the result, I finally got my money’s worth. Lol. Thank you again!”

On May 23^rd, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Medicinal Chemistry (Approval Notice).

General Field: Medicinal Chemistry

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Virginia

Approval Notice Date: May 23^rd, 2016

Processing Time: 12 months, 3 days (Premium Processing Requested)

Case Summary:

A gifted postdoctoral associate from Virginia hired North America Immigration Law Group (WeGreened.com) to file an EB-1A (Alien of Extraordinary Ability) petition on her behalf. Despite her strong credentials, the USCIS spent a year processing her case before granting their approval. It may have taken longer had our client not upgraded her case to Premium Processing (PP). Just 10 days after her case was upgraded, she received notification of case approval.

Highlighting her credentials:

Our client’s EB-1A petition packet was composed of details pertaining to her leadership role in the field of medicinal chemistry. The key points we focused on encompassed her peer review experience, publication record, and citation count. When we filed the case, these figures stood at 31 peer reviews, 11 published papers, and 129 citations to her work. Presented together, these achievements made it very clear that our client deserved to have her EB-1A petition approved. Besides her professional accomplishments, we also noted her Ph.D. in Bioorganic Chemistry and incorporated recommendation letters to strengthen the petition. These letters were readily volunteered by six experts in our client’s field. Not only did they strongly advocate for the approval of our client’s EB-1A, they also briefly discussed her research on developing a convergent method for α-ketoamide synthesis, developing Pin1 inhibitors for anticancer drug targets, understanding the Pin1 catalysis mechanism, and the cycloaddition of biologically active compounds for the development of superior therapeutic agents. Thanks to their letters, the USCIS had additional evidence that pointed to the significance of our client’s work to the U.S. medical and drug development sectors.

According to one of our client’s recommenders, a well-known professor working in the field: “It pleases me a great deal to endorse [Client’s] research in medicinal chemistry, which is exceptionally valuable for the development of drugs for treating some of the gravest diseases plaguing humanity, including cancer. She is an irreplaceable asset to the research community, producing work that is both industrially and clinical beneficial. I encourage you to allow her to continue her research in the United States, as she will continue to produce excellent findings necessary for beating cancer in her future work.”

We are pleased that the USCIS agreed with this recommender’s assessment and ultimately approved our client’s EB-1A petition. We thank our client for choosing to work with our law firm and we wish her the best as she continues to lend a hand in the evolution of medicinal chemistry.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.